Insider Stock Trading History of Chevallard Daniel R.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Chevallard Daniel R. since year 2005. The trader's CIK number is 1706176. At the time of this reporting, Chevallard Daniel R. is the Chief Financial Officer of Regulus Therapeutics Inc. . (stock ticker symbol RGLS). See this page for all insider trading activities at Regulus Therapeutics Inc. .


Stock purchases, sales, and option exercises reported by insider Chevallard Daniel R. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-07-25 RGLS Regulus Therapeutics Inc. Buy 54,945 .91 49,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chevallard Daniel R. (Chief Financial Officer of Regulus Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.